Embodiments of this disclosure relate to medical apparatus and particularly to apparatus applicable for the restoration, enhancement, or modulation of physiological functions. Specific embodiments provide apparatus for stimulating the phrenic nerves to contract the diaphragm muscle to assist breathing by transvascular electrical stimulation of nerves.
Electrical stimulation of nerves is widely applied in the treatment of a range of conditions and may be applied to control muscle activity or to generate sensations. Muscles and nerves may be stimulated by placing electrodes in, around, or near the muscles and nerves and by activating the electrodes by means of an implanted or external source of energy (e.g. electricity).
The diaphragm muscle provides important functions for respiration. The phrenic nerves normally transmit signals from the brain to cause the contractions of the diaphragm muscle necessary for breathing. However, various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include:
Intubation and positive pressure mechanical ventilation (MV) may be used for periods of several hours or several days, sometimes weeks, to help critically ill patients breathe while in intensive care units (ICU). Some patients may be unable to regain voluntary breathing and thus require prolonged or permanent mechanical ventilation. Although mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects. Mechanical ventilation:
A patient who is sedated and connected to a mechanical ventilator cannot breathe normally because the central neural drive to the diaphragm and accessory respiratory muscles is suppressed. Inactivity leads to muscle disuse atrophy and an overall decline in well-being. Diaphragm muscle atrophy occurs rapidly and can be a serious problem to the patient. According to a published study in organ donor patients (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008) after only 18 to 69 hours of mechanical ventilation, all diaphragm muscle fibers had shrunk on average by 52-57%. Muscle fiber atrophy results in muscle weakness and increased fatigability. Therefore, ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent. It has been estimated that over 600,000 US patients will be ventilator dependent and require prolonged mechanical ventilation by the year 2020 (Zilberberg et al., Critical Care Medicine, 36(5): 1451-1455, 2008).
It may also be necessary during MV to deliver or remove one or more fluids or to obtain sensor readings from within the patient. Smaller patients, such as, for example, neonates, may require smaller medical instruments to perform the aforementioned procedures. Additionally, as with any medical procedure, the risk of injury to the patient increases with the length and complexity of the medical procedure.
There remains a need for cost-effective, practical, surgically simple and minimally invasive apparatus and methods that may be applied to stimulate breathing, deliver treatment, and perform tests. There is also a need for apparatus and methods for facilitating patients on MV to regain the capacity to breathe naturally and to be weaned from MV.
Embodiments of the present disclosure relate to, among other things, medical apparatus and methods for nerve stimulation. Specific embodiments provide apparatus for stimulating breathing by trans-vascular electrical stimulation of nerves. Each of the embodiments disclosed herein may include one or more of the features described in connection with any of the other disclosed embodiments.
In one embodiment, a catheter may include an outer layer defining a plurality of apertures therethrough, and a body defining at least one longitudinal lumen therein. The body may be within the outer layer, and the apertures may be radially outward of the lumen. A plurality of electrodes may be positioned in or on the catheter, and each electrode may be electrically exposed through an aperture of the plurality of apertures, or alternatively mounted on the surface of the catheter. A ribbon cable may extend through the lumen and include a plurality of leads. The plurality of leads may electrically connect to the plurality of electrodes.
The catheter may further include one or more of the following features. The lumen may be a groove or recessed channel exposed along a portion of the circumference of the body along at least a portion of the length of the body, and the groove may be at least partially covered by an outer layer. The plurality of leads may be at least partially surrounded by a non-conducting material. The ribbon cable may include a plurality of corrugations. The catheter may also include at least one filler positioned within at least a portion of the corrugations. The corrugations may be positioned radially inward of at least one electrode. The catheter may also include at least one fluid lumen and a guide wire lumen.
Further, the catheter may include a connector feed and an application specific integrated circuit (“ASIC”) radially inward of the outer layer. The ASIC may connect the connector feed to the ribbon cable. The ribbon cable may include several, for example three, branches of ribbon cable, and the at least one longitudinal lumen may include three longitudinal lumens spaced circumferentially around an exterior of the body and radially inward of the outer layer. In this example, the three branches may extend distally from the ASIC, and each of the three branches may connect to at least one electrode through a corresponding longitudinal lumen. One branch of the three branches may include at least one lead that electrically connects at least one proximal electrode and at least one other lead that electrically connects at least one distal electrode. The plurality of apertures may include a plurality of proximal apertures and a plurality of distal apertures. The proximal apertures may include two longitudinally extending rows, and the distal apertures may include two longitudinally extending rows. One row of proximal apertures may be circumferentially aligned with one row of distal apertures. The ribbon cable may be electrically connected to at least one electrode via a connection and an electrode coupler, and the electrode coupler may longitudinally overlap with the ribbon cable and be positioned radially inward of a portion of the electrode.
In another alternative or additional embodiment, the catheter may include an outer layer defining a plurality of apertures therethrough, and a body radially within the outer layer. The catheter may also include a radial extension, extending helically around and radially outward from the body and within the outer layer, as well as a ribbon cable coupled to a plurality of electrodes. The ribbon cable may extend around an exterior of the body between portions of the radial extension, with each electrode of the plurality of electrodes electrically exposed through an aperture of the plurality of apertures, the apertures in this case being formed in an outer insulating layer over the electrodes.
The catheter may further include one or more of the following features. The plurality of electrodes may be coupled to the ribbon cable at approximately a 45 degree angle relative to a longitudinal axis of the ribbon cable. The catheter may include at least one ASIC positioned radially inward of the outer layer, and the at least one ASIC may electrically connect the ribbon cable to at least one of the plurality of electrodes. The body may include at least one groove exposed along a circumference of the body along at least a portion of the length of the body, and the at least one ASIC may be positioned within the at least one groove. The catheter may include at least one ASIC for each of the plurality of electrodes, and each ASIC may electrically connect the ribbon cable to the corresponding electrode. The catheter may include a conductive liner positioned over or within the apertures.
In another alternative or additional embodiment, the catheter may include an outer layer or sleeve. The outer layer may include first and second longitudinally extending rows of distal apertures in the outer layer, and the outer layer and/or the catheter may also include a first radiopaque feature for confirming an orientation of the first row of distal apertures relative to the second row of distal apertures.
The catheter may further include one or more of the following features. The catheter may further include first and second longitudinally extending rows of proximal apertures in the outer layer. The outer layer may include a second radiopaque feature for confirming an orientation of the first row of proximal apertures relative to the second row of proximal apertures. The first row of proximal apertures may be circumferentially aligned with one of either the first row of distal apertures or the second row of distal apertures. The second row of proximal apertures may be circumferentially offset from both the first row of distal apertures and the second row of distal apertures. The second radiopaque feature may include a radiopaque marker positioned circumferentially opposite to a line extending between the first and second rows of proximal apertures. The first radiopaque feature may be at a distal portion of the outer layer, and the second radiopaque feature may be at a proximal portion of the outer layer. The catheter may further include a hub, and the hub may include an orientation feature. The hub may also include a port configured to couple the hub to a proximal portion of the catheter in a particular orientation.
Further aspects of the disclosures and features of example embodiments are illustrated in the appended drawings and/or described in the text of this specification and/or described in the accompanying claims. It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed. As used herein, the terms “comprises,” “comprising,” or other variations thereof, are intended to cover a non-exclusive inclusion such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such a process, method, article, or apparatus. Additionally, the term “exemplary” is used herein in the sense of “example,” rather than “ideal.” As used herein, the terms “about,” “substantially,” and “approximately,” indicate a range of values within +/−5% of a stated value.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate non-limiting embodiments of the present disclosure and together with the description serve to explain the principles of the disclosure.
Throughout the following description, specific details are set forth to provide a more thorough understanding to persons skilled in the art. The following description of examples of the technology is not intended to be exhaustive or to limit the system to the precise forms of any example embodiment. Accordingly, the description and drawings are to be regarded in an illustrative, rather than a restrictive, sense.
Reference will now be made in detail to examples of the present disclosure described above and illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
The terms “proximal” and “distal” are used herein to refer to the relative positions of the components of an exemplary medical device or insertion device. When used herein, “proximal” refers to a position relatively closer to the exterior of the body or closer to an operator using the medical device or insertion device. In contrast, “distal” refers to a position relatively further away from the operator using the medical device or insertion device, or closer to the interior of the body.
General Overview
In general, embodiments of this disclosure relate to medical devices and methods for electrically stimulating a patient's nerves. In one embodiment, the patient's nerves may be stimulated to activate the diaphragm to restore or control breathing.
The medical devices described herein may include several components, including a catheter having a tubular member and one or more electrode assemblies, a signal generator to provide stimulation energy to the electrode assemblies, and one or more sensors to sense the condition of the patient and adjust the stimulation signals. The medical devices may further include a steering mechanism. Various embodiments of catheters are disclosed, including windowed catheters, multi-lumen catheters, and radiopaque catheters. In addition, various embodiments of electrode assemblies are disclosed, which may be used alone, in combination with other electrode assemblies, and with any of the disclosed tubular members that form the outer portion of the catheters.
The different embodiments of the various medical device components (e.g., electrode assemblies, steering mechanisms, etc.) may be combined and used together in any logical arrangement. Furthermore, individual features or elements of any described embodiment may be combined with or used in connection with the individual features or elements of other embodiments. The various embodiments may further be used in different contexts than those specifically described herein. For example, the disclosed electrode structures may be combined or used in combination with various deployment systems known in the art for various diagnostic and/or therapeutic applications.
During use, the medical devices (e.g., a catheter with one or more electrode assemblies) may be inserted into a patient's blood vessels such that the electrode assemblies are near the patient's nerves. The electrode assemblies may then be used for transvascular electrical stimulation of the patient's nerves. The disclosed devices may be optimized for rapid, temporary deployment in a patient and easy removal from the patient. The disclosed devices may be used, for example, for restoring breathing, treating conditions such as disuse muscle atrophy and chronic pain, or for any other procedures involving nerve stimulation. The disclosed devices may be used to treat acute or chronic conditions.
Medical Device Overview: Catheter and Electrode Assemblies
Catheter 12 may further include a manifold 32 that extends external to the patient. Electrical cable 34 and pigtail lumen 36 extend from manifold 32. Cable 34 and pigtail lumen 36 may include cable connectors 38 and 40 to connect external elements, and cable 34 may be coupled to electrical control unit 30 via cable connector 38. The cables 34 and 36 may be formed of electrical leads (not shown) that connect to electrode assemblies 14 and 16. Cable connectors 38 and 40 may be attached (e.g. by solder, crimp, PCB, etc.) to the cables 34 and 36, and one or both of cable connectors 38 and 40 may include a threading 41 (as shown in
As shown in
Catheter 12 may also include two axially extending rows of distal apertures or windows 46. Again, each axially extending row includes distal windows 46 positioned at the same circumferential position around the exterior of catheter 12, but at different axial positions along the exterior of catheter 12. The two rows of distal windows 46 may be unaligned such that one distal window 46 of a first row is axially between two distal windows 46 of a second row. For instance, as illustrated in
The proximal windows 44 and the distal windows 46 may be positioned on catheter 12 such that one row of proximal windows 44 is circumferentially aligned (i.e., the same circumferential position but different axial position) with one row of distal windows 46, but another row of proximal windows 44 and another row of distal windows 46 are each circumferentially offset from the aligned rows on the catheter 12. Proximal electrode assemblies 14 may include individual proximal electrodes 48 that are positioned to be aligned with (e.g., radially inward of and underneath) proximal windows 44, and distal electrode assemblies 16 may include individual distal electrodes 50 that are positioned to be aligned with (e.g., radially inward of and underneath) distal windows 46. Windows 44, 46 may expose electrodes 48, 50, allowing for a conductive path between sets or pairs of electrodes 48, 50 and surrounding tissue, including the blood vessel lumen in which catheter 12 is inserted.
In one embodiment illustrated in
The windows 44, 46 may be cut (e.g. by a laser, manual skive, drill, punch, etc.) through the exterior wall of catheter 12, or the windows 44, 46 may be formed by any other suitable method, such as during an extrusion process. 3-D printing, or other manufacturing process. The windows 44, 46 may extend along the longitudinal axis of catheter 12, or they may have a rectangular, oval, square, or any other shape. The windows 44, 46 may be apertures configured to allow electrical signals to travel from an interior lumen of the catheter 12 to the exterior of the catheter 12. In an additional or alternative embodiment, the windows 44, 46 may be covered by a material that allows electrical signals to pass through. As can be seen in the figures, the proximal windows 44 may be rotationally offset from the distal windows 46. In other words, in one embodiment, a straight line drawn proximally through a row of distal windows 46 does not necessarily pass through a row of proximal windows 44. In other embodiments, one or more rows of proximal windows 44 may be aligned with a corresponding row of distal windows 46. Furthermore, the characteristics of the proximal windows 44 may differ from the characteristics of the distal windows 46.
The dimensions of catheter 12 may be customized in accordance with the anatomy of a particular patient (e.g., different sizes of humans, pigs, chimpanzees, etc.). However, in some embodiments, the length of the section of the catheter 12 that includes the proximal windows 44 may be 10 cm or less, between 3-5 cm, or between 1-3 cm. The distance between two adjacent proximal windows 44 (whether the windows are circumferentially adjacent or longitudinally adjacent on the same row of windows) may be 5 cm or less, 3 cm or less, may be around 1 cm, or may be less than 1 cm. The length of the section of the catheter 12 that includes the distal windows 46 may be 6 cm or less, between 2-4 cm, or between 1-2 cm. The distance between two adjacent distal windows 46 (whether circumferentially adjacent or longitudinally adjacent on the same row of windows) may be 5 cm or less, 3 cm or less, may be around 1 cm, or may be less than 1 cm. The length of the section of the catheter 12 between proximal windows 44 and distal windows 46, which may be free of windows, may be 12 cm or less, 10 cm or less, or 8 cm or less. The windows 44, 46 may have a length of 6 mm or less, 5 mm or less, 4 mm or less, 3 mm or less, 2 mm or less, or 1 mm or less. In one embodiment, the windows 44, 46 may have a length that is less than the length of corresponding electrodes that are electrically exposed through the windows. These catheter dimensions are exemplary only, and the catheter 12 may have dimensions that vary from the above ranges and specific measurements. For neonatal applications, the distance between the distal electrodes and the proximal electrodes may be very small, perhaps less than 1 cm or even less than 1 mm. Alternatively, in this situation, a signal electrode array may contain electrode combinations which suitably serve to stimulate both the left phrenic nerve and the right phrenic nerve.
Additionally, catheter 12 may include windows 44, 46 in different configurations than discussed above. For example, catheter 12 may include more than two longitudinally extending rows of proximal windows 44 positioned at different circumferential positions. As such, catheter 12 may provide for more than two proximal electrode assemblies 14, or for two proximal electrode assemblies 14 to be positioned in different configurations in catheter 12. Alternatively or additionally, catheter 12 may be rotatable about the longitudinal axis such that windows 44, 46 at various circumferential positions may be positioned in different positions relative to the targeted nerves. Varying configurations may provide for various stimulation patterns with which catheter 12 may stimulate targeted nerves.
In one embodiment, medical system 10 may be assembled by positioning proximal and distal electrode assemblies 14, 16 within the outer, windowed tubular member of catheter 12 such that proximal electrodes 48 are at least partially exposed through proximal windows 44 and distal electrodes 50 are at least partially exposed through distal windows 46. The proximal electrode assemblies 14 may include the proximal electrodes 48 arranged and oriented to most effectively stimulate a nerve extending at transverse or right angles to the catheter 12 (e.g., the left phrenic nerve 26 in
Distal tip 42 may be a tapered distal end portion of catheter 12. Distal tip 42 may be open at the distal end to allow a guide wire 52 to pass through and distally beyond catheter 12. Distal tip 42 may have a smaller circumference than the body of catheter 12. Distal tip 42 may be softer than other portions of catheter 12, be atraumatic, and have rounded edges. Distal tip 42 may be made of an aliphatic polyester-based thermoplastic polyurethane with a portion, for example, of 20% barium sulfate. Distal tip 42 may be formed and/or coupled to a remainder of catheter 12 by melting an extruded tube of thermoplastic polyurethane in a mold using, for example, an induction heater.
The medical system 10 may be used to rhythmically activate the diaphragm by inserting the catheter 12, with one or more electrode assemblies 14 and 16, percutaneously into central veins of a patient, as shown by
Once the catheter 12 is fully inserted into the patient, various electrodes or electrode combinations can be tested to locate nerves of interest and to determine which electrodes most effectively stimulate the nerves of interest. For example, in one embodiment, testing may be done to locate the right phrenic nerve 28 and to determine which group of distal electrodes 50 in the distal electrode assemblies 16 most effectively stimulate the right phrenic nerve 28. Similarly, testing may be done to locate the left phrenic nerve 26 and to determine which group of proximal electrodes 48 in the proximal electrode assemblies 14 most effectively stimulate the left phrenic nerve 26. This testing and nerve location may be controlled and/or monitored via control unit 30, which may include testing programming and/or applications. For example, control unit 30 may test the electrodes and electrode combinations to determine which pair of bipolar distal electrodes 50 most effectively stimulate the right phrenic nerve 28, and which pair of bipolar proximal electrodes 48 most effectively stimulate the left phrenic nerve 26. Alternatively, control unit 30 may test the electrodes or electrode combinations to determine which tripolar or multipolar electrode combinations most effectively stimulate the phrenic nerves (for example, one cathode electrode and two anode electrodes, two cathode electrodes and one anode electrode, one cathode electrode and three anode electrodes, three cathode electrodes and one anode electrode, two cathode electrodes and two anode electrodes, one cathode electrode and four anode electrodes, four cathode electrodes and one anode electrode, one cathode electrode and five anode electrodes, five cathode electrodes and one anode electrode, etc.).
As a non-limiting example, testing could involve the use of a signal generator to systematically send electrical impulses to selected electrodes. By observing the patient's condition or by using sensors (either within or separate from the catheter 12), the ideal stimulation electrodes may be identified. Electrodes may serve as both stimulating electrodes and as sensing electrodes, and the medical system 10 may be integrated into a mechanical ventilator, which can be used to sense the patient's condition. Moreover, for example, control unit 30 may be programmed and/or activated to (a) select a first stimulation group of electrodes from the proximal electrode assemblies 14 to stimulate the left phrenic nerve 26, (b) select a second stimulation group of electrodes from the distal electrode assemblies 16 to stimulate the right phrenic nerve 28, (c) select a first stimulation current for the first stimulation group of electrodes to stimulate the left phrenic nerve 26, and (d) select a second stimulation current for the second stimulation group of electrodes to stimulate the right phrenic nerve 28. The selection of electrodes and current level may be pre-programmed or input based on the patient's characteristics, or the control unit 30 may test different electrode groups and current levels and monitor the patient's response to determine the electrode pairs and current levels. For example, the monitoring of the patient's response may include manual palpitation of the thoracic region, sensors to sense the movement of the patient's chest wall (e.g., accelerometers, optical devices, camera based sensors, etc.), airflow sensors, airway pressure sensors, central venous pressure sensors, etc. Control unit 30 may include a stimulation signal generator to generate the stimulation signals and to selectively transmit the generated signals to the selected electrodes.
Once ideal electrode combinations (e.g. pair, triplets, etc.) have been identified, an electrical potential may be created between a pair of selected bipolar electrodes, for example, a pair of proximal electrodes 48 each aligning with a proximal window 44. The arrangement of the electrodes 48 and the windows 44 may create an electrical field in the vicinity of windows 44, and thus in the vicinity of the targeted nerve, for example, the left phrenic nerve 26. During nerve stimulation, however, electrical current flows from one or more of the electrodes 48 to one or more of the other of the electrodes 48, flowing through the windows 44 and through the blood and surrounding tissues. The catheter 12 with windows 44 therefore acts as an insulating barrier that constrains and focuses the electrical field, rather than allowing the electrical field to expand radially outwards in all directions as the electrical field might with ring electrodes. The focused electrical field allows target nerve stimulation at lower, and thus safer, energy levels and avoids stimulating unwanted nerves or other structures. In some embodiments, the stimulation current may be between 10 and 6000 nC (nano-coulombs) or between 50-500 nC, reducing the risk of overstimulation or unwanted activation of nearby structures such as other nerves, muscles, or the heart.
In a further embodiment, any of the proximal electrodes 48 or the distal electrodes 50 may be used to measure electrical signals or other data from within the patient's body. In other words, in addition or alternatively to emitting or receiving electrical energy to produce a localized current for nerve stimulation, the electrodes 48, 50 may serve as sensors that receive electrical signals or other types of information from the patient.
Printed Ink Catheter
The exposed electrodes 48A, 50A may be coated with a conductive material (e.g., titanium nitride) in order to, for example, provide corrosion resistance and reduce the likelihood of silver oxide formation, which may be toxic. The conductive leads 54A electrically connect the proximal electrode assemblies 14A and the distal electrode assemblies 16A through cable 34 to control unit 30 or other electronics. The leads 54A connected to distal electrode assemblies 16A may travel proximally along catheter 12A beyond the proximal electrode assemblies 14A, for example, on the back side of catheter 12A in
As shown in
The use of printed electrodes and leads may reduce the overall complexity of the design while maximizing the useable catheter lumen space, without drastically changing the catheter profile or flexibility. The use of printed electrodes 14A, 16A and printed leads 54A also allows freedom of electrode position and electrode shape, permitting optimization of field focus and minimum energy for nerve recruitment and capture. Printed leads 54A may be helically disposed between printed electrodes 14A, 16A to allow for greater flexibility in bending the catheter 12A. Additionally, in some embodiments, the profile of the catheter 12A may be reduced because of the space saved by using electrodes printed on the exterior of the catheter 12A, for example, for use with neonate or other young patients. In an additional or alternative embodiment, one or several catheter lumens may be used for fluid delivery, blood sampling, central venous pressure monitoring, or to accommodate tools, sensors, or other objects. In another additional or alternative embodiment, several of the catheter lumens may be eliminated, allowing for larger catheter lumens and/or reducing the cross-sectional size of the catheter 12A.
Catheters Including Ribbon Cables
Referring now to
In one aspect, the leads may be formed by ribbon cables 70′, 70″, and 70′″. As shown in
Ribbon cables 70′, 70″, and 70′″ are flexible and include multiple insulated leads 76 (some of which are labeled in
In one example, connector feed 72 may include approximately 8 electrical leads in a ribbon cable, and ribbon cables 70′, 70″, and 70′″ may include enough electrical leads 76 to send electrical signals to each electrode 48, 50 of the proximal electrode assemblies 14 and distal electrode assemblies 16. For instance, connector feed 72 may include an electrical lead for each of power, ground, data stream, anode signal, cathode signal, and leads to send and receive signals from various elements in catheter 12. Ribbon cables 70 connect to each electrode 48, 50 of the electrode assemblies 14, 16 in order to stimulate the targeted nerves.
ASIC 74 may serve to direct the signals received from connector feed 72. For example, based on the received signals, ASIC 74 may direct electrical signals to one or a plurality of the electrodes 48, 50 of the proximal electrode assemblies 14 and the distal electrode assemblies 16. As such, there may be only one connection and/or connector at the proximal end of catheter 12 to transmit electrical or other signals distally from, for example, control unit 30, to the proximal and distal electrode assemblies 14 and 16, providing further space within tubular member 56 for the fluid lumens 60 and 62, additional medical instruments, and/or allowing the tubular member 56 and the remainder of the catheter 12 to be smaller. ASIC 74 allows for a reduction in conductors in the connector feed 72, and thus reduces the number of couplings between connector feed 72 and ASIC 74, improving reliability and reducing cost. Moreover, ASIC 74 permits the use of a connector with 8 or 9 pins, rather than a connector with 19 pins, further improving reliability and reducing the risk of signal interference or misalignment.
As shown in
In another aspect of this disclosure, the tubular member 56 may include printed ink conductors and electrodes similar to that shown in
Tubular member 56 may be extruded polyurethane (or any other suitable biocompatible material). Sheath 75 fitting over tubular member 56 may be made of any biocompatible plastic or other material. In one aspect, sheath 75 is a 0.002 m thick polyolefin shrink tube that may be positioned around tubular member 56 and shrunk down using a heat gun or other heating source. Windows 44 may be formed by ablating the heat shrink tube locally over the electrodes 48, 50 using a CO2 laser. Alternatively, sheath 75 may be a 3-D printed insulation layer with windows 44 over electrodes 48, 50 formed by open portions during the 3-D printing.
As shown in
Proximal electrode 48 may be exposed via proximal window 44 in sheath 75. A proximal electrode 48, along with the other electrodes 48, 50, may be a sheet Platinum-Iridium (Ptlr) electrode with a thickness of approximately 0.0381-0.0508 mm (0.0015-0.002 in). Ribbon cable 70″ may be coupled to the other proximal electrodes 48 and the distal electrodes 50 in the same manner as illustrated in
Each ribbon cable 70′, 70″, and 70′″ may also include corrugations 82 within at least one or more portions of grooves 64, 66, and 68. Corrugations 82 may provide greater longitudinal and lateral flexibility and bendability of the catheter 12 and the internal components. Corrugations 82 may pass underneath an electrode 48, as shown in
Electrodes 114 are mounted on helical ribbon cable 101 at an angle to the axis of the helical ribbon cable 101 such that the electrodes lie at the correct axially disposed angle when the helical ribbon cable 101 is wrapped around the tubular member 100 in the helical recess defined by radial extensions 104. After wrapping the helical ribbon cable 101 around the tubular member, the electrodes 114 adopt the alignment shown by locations 108 in
As shown in
Once positioned within a patient, the catheter 112A of
Wireless Connections to Control Unit
Instead of proximal connector 32, catheter 212 may include a manifold or hub 211 at a proximal end or coupled to the proximal end of catheter 212. Hub 211 may be positioned external to the patient when catheter 212 is inserted. Hub 211 may include a plurality of lumens that may connect to the guide wire and fluid lumens within catheter 212. In one aspect, hub 211 may be connected to a fluid port 213 and a wireless unit 215. Fluid port 213 may include one lumen connected through hub 211 to a lumen in catheter 212, or fluid port 213 may include a plurality of lumens connected through hub 211 to lumens within catheter 212, including a guide wire port. Wireless unit 215 may include a battery and a receiver/transmitter. The receiver/transmitter of wireless unit 215 may be in wireless communication with control unit 230, via, for example, a Bluetooth connection. As such, control unit 230 may send signals to and receive signals from wireless unit 215. Wireless unit 215 may then be coupled to one or more leads or ribbon cables to transmit electrical signals distally to the proximal and distal electrode assemblies 214, 216, and the signals may be distributed via one or more ASICs within catheter 212 to stimulate a target nerve.
Wireless unit 215, or catheter 212 itself, may also include a wireless information unit (not shown), for example, an RFID tag or wireless chip, or other unique coded information related to the catheter 212 including, for example, the catheter serial number and construction change level. For instance, as improvements to the catheter are made over time, each improvement is recorded as a change level. This change level may, for example, include an electrode material change or an electrode surface finish. These changes may permit the use of a more effective stimulation pulse stream. The control unit 230 may evaluate the change level code and determine whether a new stimulation program installed on the control unit 230 is applicable to that catheter 210, as the software of control unit 230 may also be updated periodically. The change level code may avoid the creation of “generic” pirated clones by detecting false codes and preventing the system from operating if a false code is detected. As such, this would also reduce the risks to the patient, medical professional, and manufacturer by eliminating the risk of inferior devices being improperly used without the proper clinical testing and approval. The wireless information unit may further record usage data for catheter 212, including, for example, time of day of use, duration of use, number of times used, and other information related to communications from control unit 230. Hub 211 with wireless unit 215 does not require a wired connection between the control unit 230 and the catheter 212, reducing the assembly time for a medical professional and reducing the risk of signal interference, misalignment, cable snagging, and other human errors.
Alternatively, though not shown, wireless unit 215 may receive all data wirelessly from control unit 230, but the low voltage power necessary for the receiver in wireless unit 215 may be delivered by a low-cost three conductor cable from the control unit 230. This arrangement allows the system to operate for long periods of time without the risk of running low on battery power. Although this arrangement requires a cable for power, the arrangement nevertheless results in a minimal number of pins in the connections to the control unit, thereby enhancing reliability and reducing the risk of misalignment.
Radiopaque Catheters and Orientation Indicators
As shown in
Catheter 312 may include a further radiopaque orientation marker, for example, orientation stripe 323. Orientation stripe 323 may extend longitudinally along at least a portion of the length of the catheter 312 such that when viewed anteriorly with an imaging system, the orientation stripe 323 passes through the middle of the catheter 312. Orientation stripe 323 may bisect or align with a midpoint of the radiopaque markers 321. Orientation stripe 323 may be positioned on catheter 312 such that, when the catheter 312 and electrodes 348, 350 are properly positioned and viewed anteriorly using an imaging system, orientation stripe 323 passes evenly between the two rows of proximal electrodes 348 and passes to the medial (patient's left) side of the one row of distal electrodes 350. Orientation stripe 323 may be formed during the formation of the catheter 312, for example, during an extrusion. Orientation stripe 323 may include a different color or pattern, may be laser marked, may be printed with radiopaque ink, may be a radiopaque wire introduced into a dedicated lumen of the catheter body, or may be formed by any other appropriate methods. If the catheter 312 is not properly positioned, the catheter 312 may be adjusted until the electrodes 348, 350, radiopaque markers 321, and orientation stripe 323 appear when viewed anteriorly as illustrated in
Orientation stripe 323 may be also be used to control the orientation of the catheter 312 while inserting catheter 312 into a patient without taking an x-ray or using another visualization technique. For example, orientation stripe 323 may run longitudinally from the distal end to the proximal end of catheter 312. Therefore, as long as the catheter 312 is not undergoing torsion, a medical professional is able to determine the orientation of the distal end, which is inserted into the patient and thus not visible without imaging technology, by observing the location of the orientation stripe 323 on the proximal end that extends proximally from the patient.
Radiopaque catheter 312 may also include an orientation hub 325. For example, the shape and size of orientation hub 325 may be such that orientation hub may be sutured or otherwise attached in only one orientation. Orientation hub 325 may have an apex 327 that circumferentially aligns with orientation stripe 323 on catheter 312, and which is opposite to a flat bottom that may rest on a patient's chest or another surface. The flat bottom may also include two attachment members or suture tabs 329 extending from the bottom such that the bottom may be coupled to other elements in the proper orientation. Additionally or alternatively, orientation hub 325 may include a wireless unit as discussed above with respect to
Catheter 312 may include all or a portion of the aforementioned positioning markers. Additionally, a medical professional may use different positioning markers to ensure the catheter 312 is positioned properly as different markers may exhibit greater visibility depending on the patient, the imaging system, and other variables. Catheter 312 and the various positioning and orientation markers may be modified and/or customized depending on the patient. For example, fewer electrodes 348, 350 may be used with a smaller patient, for example, a neonate. Alternatively, a patient with abnormal nerve locations may require a different catheter orientation and/or arrangement.
Other Alternative Embodiments and Interpretation of Terms
As noted earlier, any of the components and features of any of the embodiments disclosed herein may be combined and used in any suitable combinations with any of the other components and features disclosed herein. However, for the sake of example, some ways in which the described example embodiments may be varied include:
As mentioned above, the use of the various catheter embodiments allows for an increase in the number of available lumens within the catheter. The size of the catheter may also be reduced, for example, for use in neonatal patients or patients who require a smaller catheter. Ribbon cables increase the longitudinal flexibility of the catheter and the electrode connections during the manipulation and use of the catheter. Using ASICs and/or wireless connections reduces the number of cables and connections the medical professional must properly connect and avoid during various procedures, while still properly and accurately stimulating various internal nerves. Additionally, radiopaque catheters, radiopaque electrodes, radiopaque markers, and orientation markers may aid a medical professional in locating the position of the catheter and orienting the catheter in order to most effectively stimulate the patient's nerves.
Unless the context clearly requires otherwise, throughout the description and the claims:
Words that indicate directions such as “vertical,” “transverse,” “horizontal,” “upward,” “downward,” “forward,” “backward,” “inward,” “outward,” “left,” “right,” “front,” “back,” “top,” “bottom,” “below,” “above,” “under,” and the like, used in this description and any accompanying claims (where present), depend on the specific orientation of the apparatus described and illustrated. The subject matter described herein may assume various alternative orientations. Accordingly, these directional terms are not strictly defined and should not be interpreted narrowly.
Specific examples of systems, methods and apparatus have been described herein for purposes of illustration. These are only examples. The technology provided herein can be applied to systems other than the example systems described above. Many alterations, modifications, additions, omissions, and permutations are possible within the practice of this invention. This invention includes variations on described embodiments that would be apparent to the skilled addressee, including variations obtained by: replacing features, elements and/or acts with equivalent features, elements and/or acts; mixing and matching of features, elements and/or acts from different embodiments; combining features, elements and/or acts from embodiments as described herein with features, elements and/or acts of other technology; and/or omitting combining features, elements and/or acts from described embodiments.
It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions, omissions, and sub-combinations as may reasonably be inferred. The scope of the claims should not be limited by the preferred embodiments set forth in the examples, but should be given the broadest interpretation consistent with the description as a whole.
Number | Name | Date | Kind |
---|---|---|---|
1693734 | Waggoner | Dec 1928 | A |
2532788 | Sarnoff | Dec 1950 | A |
2664880 | Wales, Jr. | Jan 1954 | A |
3348548 | Chardack | Oct 1967 | A |
3470876 | John | Oct 1969 | A |
3769984 | Muench | Nov 1973 | A |
3804098 | Friedman | Apr 1974 | A |
3817241 | Grausz | Jun 1974 | A |
3835864 | Rasor et al. | Sep 1974 | A |
3847157 | Caillouette et al. | Nov 1974 | A |
3851641 | Toole et al. | Dec 1974 | A |
3896373 | Zelby | Jul 1975 | A |
3938502 | Bom | Feb 1976 | A |
3983881 | Wickham | Oct 1976 | A |
4054881 | Raab | Oct 1977 | A |
4072146 | Howes | Feb 1978 | A |
4114601 | Abels | Sep 1978 | A |
4173228 | Childress et al. | Nov 1979 | A |
4249539 | Mezrich et al. | Feb 1981 | A |
4317078 | Weed et al. | Feb 1982 | A |
4380237 | Newbower | Apr 1983 | A |
4407294 | Vilkomerson | Oct 1983 | A |
4416289 | Bresler | Nov 1983 | A |
4431005 | McCormick | Feb 1984 | A |
4431006 | Trimmer et al. | Feb 1984 | A |
4445501 | Bresler | May 1984 | A |
RE31873 | Howes | Apr 1985 | E |
4573481 | Bullara | Mar 1986 | A |
4586923 | Gould et al. | May 1986 | A |
4587975 | Salo et al. | May 1986 | A |
4643201 | Stokes | Feb 1987 | A |
4674518 | Salo | Jun 1987 | A |
4681117 | Brodman et al. | Jul 1987 | A |
4683890 | Hewson | Aug 1987 | A |
4697595 | Breyer et al. | Oct 1987 | A |
4706681 | Breyer et al. | Nov 1987 | A |
4771788 | Millar | Sep 1988 | A |
4819662 | Heil, Jr. et al. | Apr 1989 | A |
4827935 | Geddes et al. | May 1989 | A |
4830008 | Meer | May 1989 | A |
4840182 | Carlson | Jun 1989 | A |
4852580 | Wood | Aug 1989 | A |
4860769 | Fogarty et al. | Aug 1989 | A |
4905698 | Strohl, Jr. et al. | Mar 1990 | A |
4911174 | Pederson et al. | Mar 1990 | A |
4934049 | Kiekhafer et al. | Jun 1990 | A |
4944088 | Doan et al. | Jul 1990 | A |
4951682 | Petre | Aug 1990 | A |
4957110 | Vogel et al. | Sep 1990 | A |
4989617 | Memberg et al. | Feb 1991 | A |
5005587 | Scott | Apr 1991 | A |
5036848 | Hewson | Aug 1991 | A |
5042143 | Holleman et al. | Aug 1991 | A |
5056519 | Vince | Oct 1991 | A |
5115818 | Holleman et al. | May 1992 | A |
5146918 | Kallok et al. | Sep 1992 | A |
5170802 | Mehra | Dec 1992 | A |
5184621 | Vogel et al. | Feb 1993 | A |
5224491 | Mehra | Jul 1993 | A |
5243995 | Maier | Sep 1993 | A |
5265604 | Vince | Nov 1993 | A |
5267569 | Lienhard | Dec 1993 | A |
5314463 | Camps et al. | May 1994 | A |
5316009 | Yamada | May 1994 | A |
5324322 | Grill, Jr. et al. | Jun 1994 | A |
5330522 | Kreyenhagen | Jul 1994 | A |
5345936 | Pomeranz et al. | Sep 1994 | A |
5383923 | Webster, Jr. | Jan 1995 | A |
5411025 | Webster, Jr. | May 1995 | A |
5417208 | Winkler | May 1995 | A |
5451206 | Young | Sep 1995 | A |
5456254 | Pietroski et al. | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5476498 | Ayers | Dec 1995 | A |
5486159 | Mahurkar | Jan 1996 | A |
5507725 | Savage et al. | Apr 1996 | A |
5524632 | Stein et al. | Jun 1996 | A |
5527358 | Mehmanesh et al. | Jun 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5549655 | Erickson | Aug 1996 | A |
5555618 | Winkler | Sep 1996 | A |
5567724 | Kelleher et al. | Oct 1996 | A |
5584873 | Shoberg et al. | Dec 1996 | A |
5604231 | Smith et al. | Feb 1997 | A |
5665103 | Lafontaine et al. | Sep 1997 | A |
5678535 | Dimarco | Oct 1997 | A |
5683370 | Luther et al. | Nov 1997 | A |
5709853 | Iino et al. | Jan 1998 | A |
5716392 | Bourgeois et al. | Feb 1998 | A |
5733255 | Dinh et al. | Mar 1998 | A |
5755765 | Hyde et al. | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5779732 | Amundson | Jul 1998 | A |
5782828 | Chen et al. | Jul 1998 | A |
5785706 | Bednarek | Jul 1998 | A |
5788681 | Weaver et al. | Aug 1998 | A |
5813399 | Isaza et al. | Sep 1998 | A |
5814086 | Hirschberg et al. | Sep 1998 | A |
RE35924 | Winkler | Oct 1998 | E |
5824027 | Hoffer et al. | Oct 1998 | A |
5827192 | Gopakumaran et al. | Oct 1998 | A |
5916163 | Panescu et al. | Jun 1999 | A |
5944022 | Nardella et al. | Aug 1999 | A |
5954761 | Machek et al. | Sep 1999 | A |
5967978 | Littmann et al. | Oct 1999 | A |
5971933 | Gopakumaran et al. | Oct 1999 | A |
5983126 | Wittkampf | Nov 1999 | A |
6006134 | Hill et al. | Dec 1999 | A |
6024702 | Iversen | Feb 2000 | A |
6096728 | Collins et al. | Aug 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6123699 | Webster, Jr. | Sep 2000 | A |
6126649 | Vantassel et al. | Oct 2000 | A |
6136021 | Tockman et al. | Oct 2000 | A |
6157862 | Brownlee et al. | Dec 2000 | A |
6161029 | Spreigl et al. | Dec 2000 | A |
6166048 | Bencherif | Dec 2000 | A |
6171277 | Ponzi | Jan 2001 | B1 |
6183463 | Webster, Jr. | Feb 2001 | B1 |
6198970 | Freed et al. | Mar 2001 | B1 |
6198974 | Webster, Jr. | Mar 2001 | B1 |
6201994 | Warman et al. | Mar 2001 | B1 |
6208881 | Champeau | Mar 2001 | B1 |
6210339 | Kiepen et al. | Apr 2001 | B1 |
6212435 | Lattner et al. | Apr 2001 | B1 |
6216045 | Black et al. | Apr 2001 | B1 |
6236892 | Feler | May 2001 | B1 |
6240320 | Spehr et al. | May 2001 | B1 |
6249708 | Nelson | Jun 2001 | B1 |
6251126 | Ottenhoff et al. | Jun 2001 | B1 |
6269269 | Ottenhoff et al. | Jul 2001 | B1 |
6292695 | Webster, Jr. et al. | Sep 2001 | B1 |
6295475 | Morgan | Sep 2001 | B1 |
6360740 | Ward et al. | Mar 2002 | B1 |
6397108 | Camps et al. | May 2002 | B1 |
6400976 | Champeau | Jun 2002 | B1 |
6415183 | Scheiner et al. | Jul 2002 | B1 |
6415187 | Kuzma et al. | Jul 2002 | B1 |
6438427 | Rexhausen et al. | Aug 2002 | B1 |
6445953 | Bulkes et al. | Sep 2002 | B1 |
6449507 | Hill et al. | Sep 2002 | B1 |
6463327 | Lurie et al. | Oct 2002 | B1 |
6493590 | Wessman et al. | Dec 2002 | B1 |
6508802 | Rosengart et al. | Jan 2003 | B1 |
6526321 | Spehr | Feb 2003 | B1 |
6569114 | Ponzi et al. | May 2003 | B2 |
6584362 | Scheiner et al. | Jun 2003 | B1 |
6585718 | Hayzelden et al. | Jul 2003 | B2 |
6587726 | Lurie et al. | Jul 2003 | B2 |
6602242 | Fung et al. | Aug 2003 | B1 |
6610713 | Tracey | Aug 2003 | B2 |
6630611 | Malowaniec | Oct 2003 | B1 |
6643552 | Edell et al. | Nov 2003 | B2 |
6651652 | Waard | Nov 2003 | B1 |
6682526 | Jones et al. | Jan 2004 | B1 |
6702780 | Gilboa et al. | Mar 2004 | B1 |
6718208 | Hill et al. | Apr 2004 | B2 |
6721603 | Zabara et al. | Apr 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
6778854 | Puskas | Aug 2004 | B2 |
6779257 | Kiepen et al. | Aug 2004 | B2 |
6844713 | Steber et al. | Jan 2005 | B2 |
RE38705 | Hill et al. | Feb 2005 | E |
6881211 | Schweikert et al. | Apr 2005 | B2 |
6885888 | Rezai | Apr 2005 | B2 |
6907285 | Denker et al. | Jun 2005 | B2 |
6934583 | Weinberg et al. | Aug 2005 | B2 |
6981314 | Black et al. | Jan 2006 | B2 |
6999820 | Jordan | Feb 2006 | B2 |
7018374 | Schon et al. | Mar 2006 | B2 |
7047627 | Black et al. | May 2006 | B2 |
7071194 | Teng | Jul 2006 | B2 |
7072720 | Puskas | Jul 2006 | B2 |
7077823 | McDaniel | Jul 2006 | B2 |
7082331 | Park et al. | Jul 2006 | B1 |
7130700 | Gardeski | Oct 2006 | B2 |
7142903 | Rodriguez et al. | Nov 2006 | B2 |
7149585 | Wessman et al. | Dec 2006 | B2 |
7155278 | King et al. | Dec 2006 | B2 |
7168429 | Matthews et al. | Jan 2007 | B2 |
7184829 | Hill et al. | Feb 2007 | B2 |
7206636 | Turcott | Apr 2007 | B1 |
7212867 | Van Venrooij et al. | May 2007 | B2 |
7225016 | Koh | May 2007 | B1 |
7225019 | Jahns et al. | May 2007 | B2 |
7229429 | Martin et al. | Jun 2007 | B2 |
7231260 | Wallace et al. | Jun 2007 | B2 |
7235070 | Vanney | Jun 2007 | B2 |
7269459 | Koh | Sep 2007 | B1 |
7277757 | Casavant et al. | Oct 2007 | B2 |
7283875 | Larsson et al. | Oct 2007 | B2 |
7340302 | Falkenberg et al. | Mar 2008 | B1 |
7363085 | Benser et al. | Apr 2008 | B1 |
7363086 | Koh et al. | Apr 2008 | B1 |
7371220 | Koh et al. | May 2008 | B1 |
7416552 | Paul et al. | Aug 2008 | B2 |
7421296 | Benser et al. | Sep 2008 | B1 |
7454244 | Kassab et al. | Nov 2008 | B2 |
7519425 | Benser et al. | Apr 2009 | B2 |
7519426 | Koh et al. | Apr 2009 | B1 |
7522953 | Gharib et al. | Apr 2009 | B2 |
7553305 | Honebrink et al. | Jun 2009 | B2 |
7555349 | Wessman et al. | Jun 2009 | B2 |
7569029 | Clark et al. | Aug 2009 | B2 |
7591265 | Lee et al. | Sep 2009 | B2 |
7593760 | Rodriguez et al. | Sep 2009 | B2 |
7613524 | Jordan | Nov 2009 | B2 |
7636600 | Koh | Dec 2009 | B1 |
7670284 | Padget et al. | Mar 2010 | B2 |
7672728 | Libbus et al. | Mar 2010 | B2 |
7672729 | Koh et al. | Mar 2010 | B2 |
7676275 | Farazi et al. | Mar 2010 | B1 |
7676910 | Kiepen et al. | Mar 2010 | B2 |
7697984 | Hill et al. | Apr 2010 | B2 |
7747323 | Libbus et al. | Jun 2010 | B2 |
7771388 | Olsen et al. | Aug 2010 | B2 |
7783362 | Whitehurst et al. | Aug 2010 | B2 |
7794407 | Rothenberg | Sep 2010 | B2 |
7797050 | Libbus et al. | Sep 2010 | B2 |
7813805 | Farazi | Oct 2010 | B1 |
7819883 | Westlund et al. | Oct 2010 | B2 |
7840270 | Ignagni et al. | Nov 2010 | B2 |
7853302 | Rodriguez et al. | Dec 2010 | B2 |
7869865 | Govari et al. | Jan 2011 | B2 |
7891085 | Kuzma et al. | Feb 2011 | B1 |
7925352 | Stack et al. | Apr 2011 | B2 |
7949409 | Bly et al. | May 2011 | B2 |
7949412 | Harrison et al. | May 2011 | B1 |
7962215 | Ignagni et al. | Jun 2011 | B2 |
7970475 | Tehrani et al. | Jun 2011 | B2 |
7972323 | Bencini et al. | Jul 2011 | B1 |
7974693 | David et al. | Jul 2011 | B2 |
7974705 | Zdeblick et al. | Jul 2011 | B2 |
7979128 | Tehrani et al. | Jul 2011 | B2 |
7994655 | Bauer et al. | Aug 2011 | B2 |
8000765 | Rodriguez et al. | Aug 2011 | B2 |
8019439 | Kuzma et al. | Sep 2011 | B2 |
8021327 | Selkee | Sep 2011 | B2 |
8036750 | Caparso et al. | Oct 2011 | B2 |
8050765 | Lee et al. | Nov 2011 | B2 |
8052607 | Byrd | Nov 2011 | B2 |
8104470 | Lee et al. | Jan 2012 | B2 |
8116872 | Tehrani et al. | Feb 2012 | B2 |
8121692 | Haefner et al. | Feb 2012 | B2 |
8135471 | Zhang et al. | Mar 2012 | B2 |
8140164 | Tehrani et al. | Mar 2012 | B2 |
8147486 | Honour et al. | Apr 2012 | B2 |
8160701 | Zhao et al. | Apr 2012 | B2 |
8160711 | Tehrani et al. | Apr 2012 | B2 |
8195297 | Penner | Jun 2012 | B2 |
8200336 | Tehrani et al. | Jun 2012 | B2 |
8206343 | Racz | Jun 2012 | B2 |
8224456 | Daglow et al. | Jul 2012 | B2 |
8233987 | Gelfand et al. | Jul 2012 | B2 |
8233993 | Jordan | Jul 2012 | B2 |
8239037 | Glenn et al. | Aug 2012 | B2 |
8244358 | Tehrani et al. | Aug 2012 | B2 |
8244359 | Gelfand et al. | Aug 2012 | B2 |
8244378 | Bly et al. | Aug 2012 | B2 |
8255056 | Tehrani | Aug 2012 | B2 |
8256419 | Sinderby et al. | Sep 2012 | B2 |
8265736 | Sathaye et al. | Sep 2012 | B2 |
8265759 | Tehrani et al. | Sep 2012 | B2 |
8275440 | Rodriguez et al. | Sep 2012 | B2 |
8280513 | Tehrani et al. | Oct 2012 | B2 |
8315713 | Burnes et al. | Nov 2012 | B2 |
8321808 | Goetz et al. | Nov 2012 | B2 |
8335567 | Tehrani et al. | Dec 2012 | B2 |
8340783 | Sommer et al. | Dec 2012 | B2 |
8348941 | Tehrani | Jan 2013 | B2 |
8369954 | Stack et al. | Feb 2013 | B2 |
8374704 | Desai et al. | Feb 2013 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8388546 | Rothenberg | Mar 2013 | B2 |
8391956 | Zellers et al. | Mar 2013 | B2 |
8401640 | Zhao et al. | Mar 2013 | B2 |
8401651 | Caparso et al. | Mar 2013 | B2 |
8406883 | Barker | Mar 2013 | B1 |
8406885 | Ignagni et al. | Mar 2013 | B2 |
8412331 | Tehrani et al. | Apr 2013 | B2 |
8412350 | Bly | Apr 2013 | B2 |
8428711 | Lin et al. | Apr 2013 | B2 |
8428726 | Ignagni et al. | Apr 2013 | B2 |
8428730 | Stack et al. | Apr 2013 | B2 |
8433412 | Westlund et al. | Apr 2013 | B1 |
8442638 | Libbus et al. | May 2013 | B2 |
8457764 | Ramachandran et al. | Jun 2013 | B2 |
8467876 | Tehrani | Jun 2013 | B2 |
8473068 | Farazi | Jun 2013 | B2 |
8478412 | Ignagni et al. | Jul 2013 | B2 |
8478413 | Karamanoglu et al. | Jul 2013 | B2 |
8478426 | Barker | Jul 2013 | B2 |
8483834 | Lee et al. | Jul 2013 | B2 |
8504158 | Karamanoglu et al. | Aug 2013 | B2 |
8504161 | Kornet et al. | Aug 2013 | B1 |
8509901 | Tehrani | Aug 2013 | B2 |
8509902 | Cho et al. | Aug 2013 | B2 |
8509919 | Yoo et al. | Aug 2013 | B2 |
8512256 | Rothenberg | Aug 2013 | B2 |
8522779 | Lee et al. | Sep 2013 | B2 |
8527036 | Jalde et al. | Sep 2013 | B2 |
8532793 | Morris et al. | Sep 2013 | B2 |
8554323 | Haefner et al. | Oct 2013 | B2 |
8560072 | Caparso et al. | Oct 2013 | B2 |
8560086 | Just et al. | Oct 2013 | B2 |
8571662 | Hoffer | Oct 2013 | B2 |
8571685 | Daglow et al. | Oct 2013 | B2 |
8615297 | Sathaye et al. | Dec 2013 | B2 |
8617228 | Wittenberger et al. | Dec 2013 | B2 |
8620412 | Griffiths et al. | Dec 2013 | B2 |
8620450 | Tockman et al. | Dec 2013 | B2 |
8626292 | McCabe et al. | Jan 2014 | B2 |
8630707 | Zhao et al. | Jan 2014 | B2 |
8644939 | Wilson et al. | Feb 2014 | B2 |
8644952 | Desai et al. | Feb 2014 | B2 |
8646172 | Kuzma et al. | Feb 2014 | B2 |
8650747 | Kuzma et al. | Feb 2014 | B2 |
8676323 | Ignagni et al. | Mar 2014 | B2 |
8676344 | Desai et al. | Mar 2014 | B2 |
8694123 | Wahlstrand et al. | Apr 2014 | B2 |
8696656 | Abboud et al. | Apr 2014 | B2 |
8706223 | Zhou et al. | Apr 2014 | B2 |
8706235 | Karamanoglu et al. | Apr 2014 | B2 |
8706236 | Ignagni et al. | Apr 2014 | B2 |
8718763 | Zhou et al. | May 2014 | B2 |
8725259 | Kornet et al. | May 2014 | B2 |
8738154 | Zdeblick et al. | May 2014 | B2 |
8755889 | Scheiner | Jun 2014 | B2 |
8774907 | Rothenberg | Jul 2014 | B2 |
8781578 | McCabe et al. | Jul 2014 | B2 |
8781582 | Ziegler et al. | Jul 2014 | B2 |
8781583 | Cornelussen et al. | Jul 2014 | B2 |
8801693 | He et al. | Aug 2014 | B2 |
8805511 | Karamanoglu et al. | Aug 2014 | B2 |
8838245 | Lin et al. | Sep 2014 | B2 |
8858455 | Rothenberg | Oct 2014 | B2 |
8863742 | Blomquist et al. | Oct 2014 | B2 |
8886277 | Kim et al. | Nov 2014 | B2 |
8897879 | Karamanoglu et al. | Nov 2014 | B2 |
8903507 | Desai et al. | Dec 2014 | B2 |
8903509 | Tockman et al. | Dec 2014 | B2 |
8909341 | Gelfand et al. | Dec 2014 | B2 |
8914113 | Zhang et al. | Dec 2014 | B2 |
8918169 | Kassab et al. | Dec 2014 | B2 |
8918987 | Kuzma et al. | Dec 2014 | B2 |
8923971 | Haefner et al. | Dec 2014 | B2 |
8942823 | Desai et al. | Jan 2015 | B2 |
8942824 | Yoo et al. | Jan 2015 | B2 |
8948884 | Ramachandran et al. | Feb 2015 | B2 |
8968299 | Kauphusman et al. | Mar 2015 | B2 |
8972015 | Stack et al. | Mar 2015 | B2 |
8983602 | Sathaye et al. | Mar 2015 | B2 |
9008775 | Sathaye et al. | Apr 2015 | B2 |
9026231 | Hoffer | May 2015 | B2 |
9037264 | Just et al. | May 2015 | B2 |
9042981 | Yoo et al. | May 2015 | B2 |
9072864 | Putz | Jul 2015 | B2 |
9072899 | Nickloes | Jul 2015 | B1 |
9108058 | Hoffer | Aug 2015 | B2 |
9108059 | Hoffer | Aug 2015 | B2 |
9125578 | Grunwald | Sep 2015 | B2 |
9138580 | Ignagni et al. | Sep 2015 | B2 |
9138585 | Saha et al. | Sep 2015 | B2 |
9149642 | McCabe et al. | Oct 2015 | B2 |
9168377 | Hoffer | Oct 2015 | B2 |
9205258 | Simon et al. | Dec 2015 | B2 |
9216291 | Lee et al. | Dec 2015 | B2 |
9220898 | Hoffer | Dec 2015 | B2 |
9226688 | Jacobsen et al. | Jan 2016 | B2 |
9226689 | Jacobsen et al. | Jan 2016 | B2 |
9242088 | Thakkar et al. | Jan 2016 | B2 |
9259573 | Tehrani et al. | Feb 2016 | B2 |
9295846 | Westlund et al. | Mar 2016 | B2 |
9314618 | Imran et al. | Apr 2016 | B2 |
9333363 | Hoffer et al. | May 2016 | B2 |
9345422 | Rothenberg | May 2016 | B2 |
9370657 | Tehrani et al. | Jun 2016 | B2 |
9398931 | Wittenberger et al. | Jul 2016 | B2 |
9415188 | He et al. | Aug 2016 | B2 |
9427566 | Reed et al. | Aug 2016 | B2 |
9427588 | Sathaye et al. | Aug 2016 | B2 |
9474894 | Mercanzini et al. | Oct 2016 | B2 |
9485873 | Shah et al. | Nov 2016 | B2 |
9498625 | Bauer et al. | Nov 2016 | B2 |
9498631 | Demmer et al. | Nov 2016 | B2 |
9504837 | Demmer et al. | Nov 2016 | B2 |
9532724 | Grunwald et al. | Jan 2017 | B2 |
9533160 | Brooke et al. | Jan 2017 | B2 |
9539429 | Brooke et al. | Jan 2017 | B2 |
9545511 | Thakkar et al. | Jan 2017 | B2 |
9561369 | Burnes et al. | Feb 2017 | B2 |
9566436 | Hoffer et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9597509 | Hoffer et al. | Mar 2017 | B2 |
9615759 | Hurezan et al. | Apr 2017 | B2 |
9623252 | Sathaye et al. | Apr 2017 | B2 |
9662494 | Young et al. | May 2017 | B2 |
9682235 | O'Mahony et al. | Jun 2017 | B1 |
9694185 | Bauer | Jul 2017 | B2 |
9717899 | Kuzma et al. | Aug 2017 | B2 |
9724018 | Cho et al. | Aug 2017 | B2 |
9744351 | Gelfand et al. | Aug 2017 | B1 |
9776005 | Meyyappan et al. | Oct 2017 | B2 |
9861817 | Cho et al. | Jan 2018 | B2 |
9872989 | Jung et al. | Jan 2018 | B2 |
9884178 | Bouton et al. | Feb 2018 | B2 |
9884179 | Bouton et al. | Feb 2018 | B2 |
9919149 | Imran et al. | Mar 2018 | B2 |
9931504 | Thakkar et al. | Apr 2018 | B2 |
9950167 | Hoffer et al. | Apr 2018 | B2 |
9956396 | Young et al. | May 2018 | B2 |
9968785 | Hoffer et al. | May 2018 | B2 |
9968786 | Bauer et al. | May 2018 | B2 |
20010052345 | Niazi | Dec 2001 | A1 |
20020026228 | Schauerte | Feb 2002 | A1 |
20020056454 | Samzelius | May 2002 | A1 |
20020065544 | Smits et al. | May 2002 | A1 |
20020087156 | Maguire et al. | Jul 2002 | A1 |
20020128546 | Silver | Sep 2002 | A1 |
20020188325 | Hill et al. | Dec 2002 | A1 |
20030078623 | Weinberg et al. | Apr 2003 | A1 |
20030195571 | Burnes et al. | Oct 2003 | A1 |
20040003813 | Banner et al. | Jan 2004 | A1 |
20040010303 | Bolea et al. | Jan 2004 | A1 |
20040030362 | Hill et al. | Feb 2004 | A1 |
20040044377 | Larsson et al. | Mar 2004 | A1 |
20040064069 | Reynolds et al. | Apr 2004 | A1 |
20040077936 | Larsson et al. | Apr 2004 | A1 |
20040088015 | Casavant et al. | May 2004 | A1 |
20040111139 | McCreery | Jun 2004 | A1 |
20040186543 | King et al. | Sep 2004 | A1 |
20040210261 | King et al. | Oct 2004 | A1 |
20050004565 | Vanney | Jan 2005 | A1 |
20050013879 | Lin et al. | Jan 2005 | A1 |
20050021102 | Ignagni et al. | Jan 2005 | A1 |
20050027338 | Hill | Feb 2005 | A1 |
20050033136 | Govari et al. | Feb 2005 | A1 |
20050033137 | Oral et al. | Feb 2005 | A1 |
20050043765 | Williams et al. | Feb 2005 | A1 |
20050065567 | Lee et al. | Mar 2005 | A1 |
20050070981 | Verma | Mar 2005 | A1 |
20050075578 | Gharib et al. | Apr 2005 | A1 |
20050085865 | Tehrani | Apr 2005 | A1 |
20050085866 | Tehrani | Apr 2005 | A1 |
20050085867 | Tehrani et al. | Apr 2005 | A1 |
20050085868 | Tehrani et al. | Apr 2005 | A1 |
20050085869 | Tehrani et al. | Apr 2005 | A1 |
20050096710 | Kieval | May 2005 | A1 |
20050109340 | Tehrani | May 2005 | A1 |
20050113710 | Stahmann et al. | May 2005 | A1 |
20050115561 | Stahmann et al. | Jun 2005 | A1 |
20050131485 | Knudson et al. | Jun 2005 | A1 |
20050138791 | Black et al. | Jun 2005 | A1 |
20050138792 | Black et al. | Jun 2005 | A1 |
20050143787 | Boveja et al. | Jun 2005 | A1 |
20050165457 | Benser et al. | Jul 2005 | A1 |
20050182454 | Gharib et al. | Aug 2005 | A1 |
20050187584 | Denker et al. | Aug 2005 | A1 |
20050192655 | Black et al. | Sep 2005 | A1 |
20050251238 | Wallace et al. | Nov 2005 | A1 |
20050251239 | Wallace et al. | Nov 2005 | A1 |
20050288728 | Libbus et al. | Dec 2005 | A1 |
20050288730 | Deem et al. | Dec 2005 | A1 |
20060030894 | Tehrani | Feb 2006 | A1 |
20060035849 | Spiegelman et al. | Feb 2006 | A1 |
20060058852 | Koh et al. | Mar 2006 | A1 |
20060074449 | Denker et al. | Apr 2006 | A1 |
20060122661 | Mandell | Jun 2006 | A1 |
20060122662 | Tehrani et al. | Jun 2006 | A1 |
20060130833 | Younes | Jun 2006 | A1 |
20060142815 | Tehrani et al. | Jun 2006 | A1 |
20060149334 | Tehrani et al. | Jul 2006 | A1 |
20060155222 | Sherman et al. | Jul 2006 | A1 |
20060167523 | Tehrani et al. | Jul 2006 | A1 |
20060188325 | Dolan | Aug 2006 | A1 |
20060195159 | Bradley et al. | Aug 2006 | A1 |
20060217791 | Spinka | Sep 2006 | A1 |
20060224209 | Meyer | Oct 2006 | A1 |
20060229677 | Moffitt et al. | Oct 2006 | A1 |
20060247729 | Tehrani et al. | Nov 2006 | A1 |
20060253161 | Libbus et al. | Nov 2006 | A1 |
20060253182 | King | Nov 2006 | A1 |
20060258667 | Teng | Nov 2006 | A1 |
20060259107 | Caparso et al. | Nov 2006 | A1 |
20060282131 | Caparso et al. | Dec 2006 | A1 |
20060287679 | Stone | Dec 2006 | A1 |
20070005053 | Dando | Jan 2007 | A1 |
20070021795 | Tehrani | Jan 2007 | A1 |
20070027448 | Paul | Feb 2007 | A1 |
20070087314 | Gomo | Apr 2007 | A1 |
20070093875 | Chavan et al. | Apr 2007 | A1 |
20070106357 | Denker et al. | May 2007 | A1 |
20070112402 | Grill et al. | May 2007 | A1 |
20070112403 | Moffitt et al. | May 2007 | A1 |
20070118183 | Gelfand et al. | May 2007 | A1 |
20070150006 | Libbus et al. | Jun 2007 | A1 |
20070168007 | Kuzma et al. | Jul 2007 | A1 |
20070173900 | Siegel et al. | Jul 2007 | A1 |
20070191908 | Jacob et al. | Aug 2007 | A1 |
20070196780 | Ware et al. | Aug 2007 | A1 |
20070203549 | Demarais et al. | Aug 2007 | A1 |
20070208388 | Jahns et al. | Sep 2007 | A1 |
20070221224 | Pittman et al. | Sep 2007 | A1 |
20070240718 | Daly | Oct 2007 | A1 |
20070250056 | Vanney | Oct 2007 | A1 |
20070250162 | Royalty | Oct 2007 | A1 |
20070255379 | Williams et al. | Nov 2007 | A1 |
20070265611 | Ignagni et al. | Nov 2007 | A1 |
20070288076 | Bulkes et al. | Dec 2007 | A1 |
20080039916 | Colliou et al. | Feb 2008 | A1 |
20080065002 | Lobl et al. | Mar 2008 | A1 |
20080125828 | Ignagni et al. | May 2008 | A1 |
20080161878 | Tehrani et al. | Jul 2008 | A1 |
20080167695 | Tehrani et al. | Jul 2008 | A1 |
20080177347 | Tehrani et al. | Jul 2008 | A1 |
20080183186 | Bly et al. | Jul 2008 | A1 |
20080183187 | Bly | Jul 2008 | A1 |
20080183239 | Tehrani et al. | Jul 2008 | A1 |
20080183240 | Tehrani et al. | Jul 2008 | A1 |
20080183253 | Bly | Jul 2008 | A1 |
20080183254 | Bly et al. | Jul 2008 | A1 |
20080183255 | Bly et al. | Jul 2008 | A1 |
20080183259 | Bly et al. | Jul 2008 | A1 |
20080183264 | Bly et al. | Jul 2008 | A1 |
20080183265 | Bly et al. | Jul 2008 | A1 |
20080188903 | Tehrani et al. | Aug 2008 | A1 |
20080215106 | Lee et al. | Sep 2008 | A1 |
20080288010 | Tehrani et al. | Nov 2008 | A1 |
20080288015 | Tehrani et al. | Nov 2008 | A1 |
20080312712 | Penner | Dec 2008 | A1 |
20080312725 | Penner | Dec 2008 | A1 |
20090024047 | Shipley et al. | Jan 2009 | A1 |
20090036947 | Westlund et al. | Feb 2009 | A1 |
20090118785 | Ignagni et al. | May 2009 | A1 |
20090248122 | Pianca | Oct 2009 | A1 |
20090275956 | Burnes et al. | Nov 2009 | A1 |
20090275996 | Burnes et al. | Nov 2009 | A1 |
20090276022 | Burnes et al. | Nov 2009 | A1 |
20100022950 | Anderson et al. | Jan 2010 | A1 |
20100036451 | Hoffer | Feb 2010 | A1 |
20100077606 | Black et al. | Apr 2010 | A1 |
20100094376 | Penner | Apr 2010 | A1 |
20100114227 | Cholette | May 2010 | A1 |
20100114254 | Kornet | May 2010 | A1 |
20100198296 | Ignagni et al. | Aug 2010 | A1 |
20100204766 | Zdeblick et al. | Aug 2010 | A1 |
20100268311 | Cardinal et al. | Oct 2010 | A1 |
20100319691 | Lurie et al. | Dec 2010 | A1 |
20110060381 | Ignagni et al. | Mar 2011 | A1 |
20110077726 | Westlund et al. | Mar 2011 | A1 |
20110118815 | Kuzma et al. | May 2011 | A1 |
20110230932 | Tehrani et al. | Sep 2011 | A1 |
20110230935 | Zdeblick | Sep 2011 | A1 |
20110230945 | Ohtaka et al. | Sep 2011 | A1 |
20110270358 | Davis et al. | Nov 2011 | A1 |
20110288609 | Tehrani et al. | Nov 2011 | A1 |
20120035684 | Thompson et al. | Feb 2012 | A1 |
20120053654 | Tehrani et al. | Mar 2012 | A1 |
20120078320 | Schotzko et al. | Mar 2012 | A1 |
20120130217 | Kauphusman et al. | May 2012 | A1 |
20120158091 | Tehrani et al. | Jun 2012 | A1 |
20120209284 | Westlund et al. | Aug 2012 | A1 |
20120215278 | Penner | Aug 2012 | A1 |
20120323293 | Tehrani et al. | Dec 2012 | A1 |
20130018247 | Glenn et al. | Jan 2013 | A1 |
20130018427 | Pham et al. | Jan 2013 | A1 |
20130023972 | Kuzma et al. | Jan 2013 | A1 |
20130030496 | Karamanoglu et al. | Jan 2013 | A1 |
20130030497 | Karamanoglu et al. | Jan 2013 | A1 |
20130030498 | Karamanoglu et al. | Jan 2013 | A1 |
20130060245 | Grunewald et al. | Mar 2013 | A1 |
20130116743 | Karamanoglu et al. | May 2013 | A1 |
20130123891 | Swanson | May 2013 | A1 |
20130131743 | Yamasaki et al. | May 2013 | A1 |
20130158625 | Gelfand et al. | Jun 2013 | A1 |
20130165989 | Gelfand et al. | Jun 2013 | A1 |
20130167372 | Black et al. | Jul 2013 | A1 |
20130197601 | Tehrani et al. | Aug 2013 | A1 |
20130237906 | Park et al. | Sep 2013 | A1 |
20130268018 | Brooke et al. | Oct 2013 | A1 |
20130289686 | Masson et al. | Oct 2013 | A1 |
20130296964 | Tehrani | Nov 2013 | A1 |
20130296973 | Tehrani et al. | Nov 2013 | A1 |
20130317587 | Barker | Nov 2013 | A1 |
20130333696 | Lee et al. | Dec 2013 | A1 |
20140067032 | Morris et al. | Mar 2014 | A1 |
20140088580 | Wittenberger et al. | Mar 2014 | A1 |
20140114371 | Westlund et al. | Apr 2014 | A1 |
20140121716 | Casavant et al. | May 2014 | A1 |
20140128953 | Zhao et al. | May 2014 | A1 |
20140148780 | Putz | May 2014 | A1 |
20140316486 | Zhou et al. | Oct 2014 | A1 |
20140324115 | Ziegler et al. | Oct 2014 | A1 |
20140378803 | Geistert et al. | Dec 2014 | A1 |
20150018839 | Morris et al. | Jan 2015 | A1 |
20150034081 | Tehrani et al. | Feb 2015 | A1 |
20150045810 | Hoffer et al. | Feb 2015 | A1 |
20150045848 | Cho et al. | Feb 2015 | A1 |
20150119950 | Demmer et al. | Apr 2015 | A1 |
20150148877 | Thakkar | May 2015 | A1 |
20150165207 | Karamanoglu | Jun 2015 | A1 |
20150196354 | Haverkost et al. | Jul 2015 | A1 |
20150196356 | Kauphusman et al. | Jul 2015 | A1 |
20150231348 | Lee et al. | Aug 2015 | A1 |
20150250982 | Osypka | Sep 2015 | A1 |
20150265833 | Meyyappan et al. | Sep 2015 | A1 |
20150283340 | Zhang et al. | Oct 2015 | A1 |
20150290476 | Krocak et al. | Oct 2015 | A1 |
20150359487 | Coulombe | Dec 2015 | A1 |
20150374252 | De La Rama et al. | Dec 2015 | A1 |
20150374991 | Morris et al. | Dec 2015 | A1 |
20160001072 | Gelfand et al. | Jan 2016 | A1 |
20160101280 | Thakkar | Apr 2016 | A1 |
20160144078 | Young et al. | May 2016 | A1 |
20160193460 | Xu et al. | Jul 2016 | A1 |
20160228696 | Imran et al. | Aug 2016 | A1 |
20160239627 | Cerny et al. | Aug 2016 | A1 |
20160256692 | Baru | Sep 2016 | A1 |
20160310730 | Martins et al. | Oct 2016 | A1 |
20160331326 | Xiang et al. | Nov 2016 | A1 |
20160367815 | Hoffer | Dec 2016 | A1 |
20170007825 | Thakkar et al. | Jan 2017 | A1 |
20170013713 | Shah et al. | Jan 2017 | A1 |
20170021166 | Bauer et al. | Jan 2017 | A1 |
20170028191 | Mercanzini et al. | Feb 2017 | A1 |
20170036017 | Tehrani et al. | Feb 2017 | A1 |
20170050033 | Wechter | Feb 2017 | A1 |
20170143973 | Tehrani | May 2017 | A1 |
20170143975 | Hoffer et al. | May 2017 | A1 |
20170196503 | Narayan et al. | Jul 2017 | A1 |
20170224993 | Sathaye et al. | Aug 2017 | A1 |
20170232250 | Kim et al. | Aug 2017 | A1 |
20170252558 | O'Mahony et al. | Sep 2017 | A1 |
20170291023 | Kuzma et al. | Oct 2017 | A1 |
20170296812 | O'Mahony et al. | Oct 2017 | A1 |
20170312006 | McFarlin et al. | Nov 2017 | A1 |
20170312507 | Bauer et al. | Nov 2017 | A1 |
20170312508 | Bauer et al. | Nov 2017 | A1 |
20170312509 | Bauer et al. | Nov 2017 | A1 |
20170326359 | Gelfand et al. | Nov 2017 | A1 |
20170347921 | Haber et al. | Dec 2017 | A1 |
20180001086 | Bartholomew et al. | Jan 2018 | A1 |
20180008821 | Gonzalez et al. | Jan 2018 | A1 |
20180110562 | Govari et al. | Apr 2018 | A1 |
20180117334 | Jung | May 2018 | A1 |
Number | Date | Country |
---|---|---|
1652839 | Aug 2005 | CN |
102143781 | Aug 2011 | CN |
0993840 | Apr 2000 | EP |
1304135 | Apr 2003 | EP |
0605796 | Aug 2003 | EP |
2489395 | Aug 2012 | EP |
2801509 | Jun 2001 | FR |
H08510677 | Nov 1996 | JP |
2003503119 | Jan 2003 | JP |
2010516353 | May 2010 | JP |
2011200571 | Oct 2011 | JP |
2012000195 | Jan 2012 | JP |
9407564 | Apr 1994 | WO |
9508357 | Mar 1995 | WO |
9964105 | Dec 1999 | WO |
9965561 | Dec 1999 | WO |
0100273 | Jan 2001 | WO |
02058785 | Aug 2002 | WO |
03094855 | Nov 2003 | WO |
2006110338 | Oct 2006 | WO |
2006115877 | Nov 2006 | WO |
2007053508 | May 2007 | WO |
2008092246 | Aug 2008 | WO |
2008094344 | Aug 2008 | WO |
2009006337 | Jan 2009 | WO |
2009134459 | Nov 2009 | WO |
2010029842 | Mar 2010 | WO |
2010148412 | Dec 2010 | WO |
2011158410 | Dec 2011 | WO |
2012106533 | Aug 2012 | WO |
2013131187 | Sep 2013 | WO |
2013188965 | Dec 2013 | WO |
2015075548 | May 2015 | WO |
2015109401 | Jul 2015 | WO |
Entry |
---|
Atonica A., et al., “Vagal Control of Lymphocyte Release from Rat Thymus,” Journal of the Autonomic Nervous System, Elsevier, vol. 48(3), Aug. 1994, pp. 187-197. |
Whaley K., et al., “C2 Synthesis by Human Monocytes is Modulated by a Nicotinic Cholinergic Receptor,” Nature, vol. 293, Oct. 15, 1981, pp. 580-582 (and reference page). |
Borovikovaa L.V., et al., “Role of Vagus Nerve Signaling in CNI-1493-Mediated Suppression of Acute Inflammation,” Autonomic Neuroscience: Basic and Clinical, vol. 85 (1-3), Dec. 20, 2000, pp. 141-147. |
Borovikovaa L.V., et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin,” Mature, Macmillan Magazines Ltd, vol. 405, May 25, 2000, pp. 458-462. |
Watkins L.R., et al., “Implications of Immune-to-Brain Communication for Sickness and Pain,” PNAS (Proceedings of the National Academy of Sciences of the USA), vol. 96 (14), Jul. 6, 1999, pp. 7710-7713. |
Extended European Search Report for Application No. 14864542.7, dated Jun. 2, 2017, 8 pages. |
Fleshner M., et al., “Thermogenic and Corticosterone Responses to Intravenous Cytokines (IL-1β and TNF-α) are Attenuated by Subdiaphragmatic Vagotomy,” Journal of Neuroimmunology, vol. 86, Jun. 1998, pp. 134-141. |
Gaykema R.P.A. et al., “Subdiaphragmatic Vagotomy Suppresses Endotoxin-Induced Activation of Hypothalamic Corticotropin-Releasing Hormone Neurons and ACTH Secretion,” Endocrinology, The Endocrine Society, vol. 136 (10), 1995, pp. 4717-4720. |
Gupta A.K., “Respiration Rate Measurement Based on Impedance Pneumography,” Data Acquisition Products, Texas Instruments, Application Report, SBAA181, Feb. 2011, 11 pages. |
Guslandi M., “Nicotine Treatment for Ulcerative Colitis,” The British Journal of Clinical Pharmacology, Blackwell Science Ltd, vol. 48, 1999, pp. 481-484. |
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Dec. 6, 2016, 4 pages. |
Kawashima K., et al., “Extraneuronal Cholinergic System in Lymphocytes,” Pharmacology & Therapeutics, Elsevier, vol. 86, 2000, pp. 29-48. |
Madretsma, G.S., et al., “Nicotine Inhibits the In-vitro Production of Interleukin 2 and Tumour Necrosis Factor-α by Human Mononuclear Cells,” Immunopharmacology, Elsevier, vol. 35 (1), Oct. 1996, pp. 47-51. |
Nabutovsky, Y., et al., “Lead Design and Initial Applications of a New Lead for Long-Term Endovascular Vagal Stimulation,” PACE, Blackwell Publishing, Inc, vol. 30(1), Jan. 2007, pp. S215-S218. |
Pavlovic D., et al., “Diaphragm Pacing During Prolonged Mechanical Ventilation of the Lungs could Prevent from Respiratory Muscle Fatigue,” Medical Hypotheses, vol. 60 (3), 2003, pp. 398-403. |
Planas R.F., et al., “Diaphragmatic Pressures: Transvenous vs. Direct Phrenic Nerve Stimulation,” Journal of Applied Physiology, vol. 59(1), 1985, pp. 269-273. |
Romanovsky, A.A., et al., “The Vagus Nerve in the Thermoregulatory Response to Systemic Inflammation,” American Journal of Physiology, vol. 273 (1 Pt 2), 1997, pp. R407-R413. |
Salmela L., et al., “Verification of the Position of a Central Venous Catheter by Intra-Atrial ECG. When does this method fail?,” Acta Anasthesiol Scand, Vol. 37 (1), 1993, pp. 26-28. |
Sandborn W.J., “Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis,” Annals of Internal Medicine, vol. 126 (5), Mar. 1, 1997, pp. 364-371. |
Sato E., et al., “Acetylcholine Stimulates Alveolar Macrophages to Release Inflammatory Cell Chemotactic Activity,” American Journal of Physiology, vol. 274 (Lung Cellular and Molecular Physiology 18), 1998, pp. L970-L979. |
Sato, K.Z., et al., “Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines,” Neuroscience Letters, vol. 266 (1), 1999, pp. 17-20. |
Schauerte P., et al., “Transvenous Parasympathetic Nerve Stimulation in the Inferior Vena Cava and Atrioventricular Conduction,” Journal of Cardiovascular Electrophysiology, vol. 11 (1), Jan. 2000, pp. 64-69. |
Schauerte P.N., et al., “Transvenous Parasympathetic Cardiac Nerve Stimulation: An Approach for Stable Sinus Rate Control,” Journal of Cardiovascular Electrophysiology, vol. 10 (11), Nov. 1999, pp. 1517-1524. |
Scheinman R.I., et al., “Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids,” Science, vol. 270, Oct. 13, 1995, pp. 283-286. |
Sher, M.E., et al., “The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease,” Inflammatory Bowel Diseases, vol. 5 (2), May 1999, pp. 73-78. |
Steinlein, O., “New Functions for Nicotinic Acetylcholine Receptors?,” Behavioural Brain Research, vol. 95, 1998, pp. 31-35. |
Sternberg E.M., (Series Editor) “Neural-Immune Interactions in Health and Disease,” The Journal of Clinical Investigation, vol. 100 (11), Dec. 1997, pp. 2641-2647. |
Sykes., A.P., et al. “An Investigation into the Effect and Mechanisms of Action of Nicotine in Inflammatory Bowel Disease,” Inflammation Research, vol. 49, 2000, pp. 311-319. |
Toyabe S., et al., “Identification of Nicotinic Acetylcholine Receptors on Lymphocytes in the Periphery as well as Thymus in Mice,” Immunology, vol. 92, 1997, pp. 201-205. |
Van Dijk A.P.M., et al., “Transdermal Nicotine Inhibits Interleukin 2 Synthesis by Mononuclear Cells Derived from Healthy Volunteers,” European Journal of Clinical Investigation, vol. 28, 1998, pp. 664-671. |
Watkins L.R., et al., “Blockade of Interleukin-1 Induced Hyperthermia by Subdiaphragmatic Vagotomy: Evidence for Vagal Mediation of Immune-Brain Communication,” Neuroscience Letters, vol. 183, 1995, pp. 27-31. |
Ayas N.T., et al., “Prevention of Human Diaphragm Atrophy with Short periods of Electrical Stimulation,” American Journal of Respiratory and Critical Care Medicine, Jun. 1999, vol. 159(6), pp. 2018-2020. |
Borovikova, et al., “Role of the Vagus Nerve in the Anti-Inflammatory Effects of CNI-1493,” Proceedings of the Annual Meeting of Professional Research Scientists: Experimental Biology 2000, Abstract 97.9, Apr. 15-18, 2000. |
Chinese Search Report for Application No. CN2013/80023357.5, dated Jul. 24, 2015. |
Co-pending U.S. Appl. No. 15/606,867, filed May 26, 2017. |
Daggeti, W.M. et al., “Intracaval Electrophrenic Stimulation. I. Experimental Application during Barbiturate Intoxication Hemorrhage and Gang,” Journal of Thoracic and Cardiovascular Surgery, 1966, vol. 51 (5), pp. 676-884. |
Daggeti, W.M. et al., “Intracaval electrophrenic stimulation. II. Studies on Pulmonary Mechanics Surface Tension Urine Flow and Bilateral Ph,” Journal of Thoracic and Cardiovascular Surgery, 1970, vol. 60(1 ), pp. 98-107. |
De Gregorio, M.A. et al., “The Gunther Tulip Retrievable Filter: Prolonged Temporary Filtration by Repositioning within the Inferior Vena Cava,” Journal of Vascular and Interventional Radiology, 2003, vol. 14, pp. 1259-1265. |
Deng Y-J et al., “The Effect of Positive Pressure Ventilation Combined with Diaphragm Pacing on Respiratory Mechanics in Patients with Respiratory Failure; Respiratory Mechanics,” Chinese critical care medicine, Apr. 2011, vol. 23(4), pp. 213-215. |
European Search Report for Application No. 13758363, dated Nov. 12, 2015. |
European Search Report for Application No. EP17169051.4, dated Sep. 8, 2017, 7 pages. |
Extended European Search Report for Application No. 15740415.3, dated Jul. 7, 2017. |
Frisch S., “A Feasibility Study of a Novel Minimally Invasive Approach for Diaphragm Pacing,” Master of Science Thesis, Simon Fraser University, 2009, p. 148. |
Furman, S., “Transvenous Stimulation of the Phrenic Nerves,” Journal of Thoracic and Cardiovascular Surgery, 1971, vol. 62 (5), pp. 743-751. |
Hoffer J.A. et al., “Diaphragm Pacing with Endovascular Electrodes”, IFESS 2010—International Functional Electrical Stimulation Society, 15th Anniversary Conference, Vienna, Austria, Sep. 2010. |
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Oct. 17, 2017, 5 pages. |
Levine S., et al., “Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans,” New England Journal of Medicine, 2008, vol. 358, pp. 1327-1335. |
Lungpacer: Therapy, News . . . Accessed Dec. 27, 2016. |
Marcy, T.W. et al., “Diaphragm Pacing for Ventilatory Insufficiency,” Journal of Intensive Care Medicine, 1987, vol. 2 (6), pp. 345-353. |
Meyyappan R., “Diaphragm Pacing during Controlled Mechanical Ventilation: Pre-Clinical Observations Reveal a Substantial Improvement in Respiratory Mechanics”, 17th Biennial Canadian Biomechanics Society Meeting, Burnaby, BC, Jun. 6-9, 2012. |
Notification of Reasons for Rejection and English language translation issued in corresponding Japanese Patent Application No. 2015-517565, dated Mar. 28, 2017, 6 pages. |
Onders R.,, “A Diaphragm Pacing as a Short-Term Assist to Positive Pressure Mechanical Ventilation in Critical Care Patients,” Chest, Oct. 24, 2007, vol. 132(4), pp. 5715-5728. |
Onders R.,, “Diaphragm Pacing for Acute Respiratory Failure,” Difficult Decisions in Thoracic Surgery, Chapter 37, Springer-Verlag, 2011, M.K. Ferguson (ed.), pp. 329-335. |
Onders R, et al., “Diaphragm Pacing with Natural Orifice Transluminal Endoscopic Surgery: Potential for Difficult-to-Wean Intensive Care Unit Patients,” Surgical Endoscopy, 2007, vol. 21, pp. 475-479. |
Sandoval R., “A Catch/Ike Property-Based Stimulation Protocol for Diaphragm Pacing”, Master of Science Coursework project, Simon Fraser University, Mar. 2013. |
Sarnoff, S.J. et al., “Electrophrenic Respiration,” Science, 1948, vol. 108, p. 482. |
Wanner, A. et al., “Trasvenous Phrenic Nerve Stimulation in Anesthetized Dogs,” Journal of Applied Physiology, 1973, vol. 34 (4), pp. 489-494. |
PCT Search Report dated Oct. 26, 2018 for PCT Application No. PCT/IB2018/000603, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20180339156 A1 | Nov 2018 | US |